Nanobiotix Stock: Decline of 5.09% at Close Amid Short Position Disclosure
Nanobiotix shares ended the session on Wednesday, October 22, down by 5.09%, at 19.22 euros. This correction occurs in a context of increased volatility for the stock specialized in oncological nanomedicines.
Closing Figures and Weekly Overview
At the close, the stock stood at 19.22 euros, down 5.09% from the previous day when it was quoted at 20.25 euros. Trading volumes remained moderate, with 1.34% of the capital changing hands during the session. This correction is part of a challenging week for the stock, which has seen a decline of 19.92% over seven days. Despite this recent downturn, Nanobiotix still boasts spectacular performances over longer horizons. The stock has risen by 340.3% over three months and by 326% over a year, performances that starkly contrast with the evolution of the CAC 40, which is up 8.9% over twelve months. This momentum reflects the continuing interest in the company's developments in the field of nanoparticle-enhanced radiotherapy.
Regulatory Disclosure by Financial Authorities
The Financial Markets Authority published on Wednesday afternoon a declaration of a net short position held by Voleon Capital Management LP. This position amounts to 0.49% of Nanobiotix's capital, in accordance with Article 9 of the European regulation on transparency of short positions. This publication, dated October 22, comes in a context of high volatility for the stock of the French biotech. The declaration of such short positions is mandatory when they exceed certain thresholds set by European regulation. Voleon Capital Management LP, an American asset manager, thus joins the list of funds that have declared a selling position on the stock.
Technical Analysis and Market Indicators
Technically, the stock is now well above its moving averages, whether it be the 50-day average at 12.58 euros or the 200-day average at 5.98 euros. The RSI at 62 is in a neutral zone, suggesting that the stock is neither overbought nor oversold. The MACD shows a slightly negative histogram at -0.25, with the signal line at 3.35 being higher than the MACD line at 3.10. The Bollinger Bands frame the price between a theoretical support at 11.20 euros and a resistance at 27.30 euros, reflecting the amplitude of recent movements. The one-month volatility stands at 33.10, confirming the turbulent nature of the trading. The stock has a technical support threshold identified at 7.95 euros and a resistance at 24.45 euros, while the negative beta coefficient at -0.34 indicates a decoupling from overall market movements.
